🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide SYNCHRONIZE Phase 3 — November 2025 Page 11

Survodutide SYNCHRONIZE Phase 3 — November 2025

ZaraB_AL Thu, Sep 12, 2024 at 4:18 AM 56 replies 2,243 viewsPage 11 of 12
FitDadDave
Member
534
2,678
Jul 2024
Minneapolis, MN
Apr 28, 2025 at 7:56 AM#51
SleepDoc_PDX said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

I read this differently from SleepDoc_PDX, on substance rather than tone. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.

28 1Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 25 others
Reply Quote Save Share Report
MaxMetOK
Member
312
1,123
Dec 2024
Oklahoma
May 5, 2025 at 3:00 AM#52
SleepDoc_PDX said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.

Last edited: May 5, 2025 at 8:00 AM
29 2TomTeleRx, DoseLogDan, SleepFixSam and 26 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
May 11, 2025 at 10:00 PM#53
SleepDoc_PDX said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

30 3tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 27 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
May 18, 2025 at 4:56 PM#54

Adding the clinical framing, because it changes how the question reads. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

Last edited: May 18, 2025 at 6:56 PM
31 4NurseKim_ATL, paul_denver, TinaHashiRN and 28 others
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
May 25, 2025 at 11:48 AM#55
EndoResFellow said:
It helps to ask what evidence would change your mind before you look at any.

Adding a me-too, because a thread of one person's experience is not much use. Posting only so the count is not one.

Last edited: May 25, 2025 at 1:48 PM
32 5tampaLisa73, KarenAZ_mom, zoe_NC and 29 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register